If they're not, they must be cooking the books. There's that red herring of R&D costs, most of which are covered by our taxes for universities. I will give you that their advertising budgets are YOOJ, much greater than R&D. There's a reason drug costs here are astronomically higher than anywhere else; we've elevated greed to the status of a virtue, and there are few laws in place to protect the patient.
I work in small pharma. We don't produce widgets in sweat shops, we employ the best and brightest who spend years developing a few products that take more years of clinical trials and regulatory submissions to gain approval for sale, which doesn't always pan out. We then have a limited life span on the product before it's eligible for the generic market. We are the most highly regulated manufacturers on the planet. We're expensive, otherwise we couldn't exist.
"Things should be made as simple as possible, but not one bit simpler." ~ Albert Einstein
Home phones for the poor, is something I looked into, as I wanted that service but found I didn't qualify. It is called Lifeline service, and back then was something like $7 a month (before the taxes, which were 50% of my bill). I personally thing the big thing against the "Obamaphone" is both the fact that tents were set up and they were offering it to everyone (fraud), as well as not enforcing it the same as Lifeline service (I was offered one twice), as well as what you got with it: (think about how the news makes these your spokespeople)
So, you're saying I can't find any big pharma outfits on the DOW/NASDAQ that have higher-than-market returns over time, to pad my retirement portfolio with? Darn. Seemed like an easy score.
Probably the books-cooking theory is correct, after all, nobody ever audits these corporations or looks at the books, especially shareholders or regulators. All that cash, secretly hiding in a vault somewhere...
There are currently 1 users browsing this thread. (0 members and 1 guests)